KYTX vs ROST · $488.8M cap vs P/E 21, rev $22.75B
Kyverna Therapeutics, Inc. Common Stock (KYTX) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
KYTX does not have a complete income-statement cache yet.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
KYTX currently screens at market cap $488.8M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the KYTX and ROST stock pages for the full models.
Not investment advice.